Multi drug resistant tuberculosis
- PMID: 8644369
Multi drug resistant tuberculosis
Abstract
The prevalence of multi-drug resistant tuberculosis is increasing globally which has upset tuberculosis treatment and control programmes. The problem has been further complicated by co-infection with HIV virus. Treatment of multi drug resistant tuberculosis is difficult, expensive and requires long duration chemotherapy. The long term prognosis is poor with frequent relapses following cessation of treatment. Health care workers are at considerable risk of contacting the disease. New, potent and less toxic drugs are required for management of multi drug resistant strains. Directly observed therapy of tuberculosis seems to be promising but demands enormous resources. Finally strengthening of tuberculosis control programmes for prevention and control of tuberculosis is essential.
Similar articles
-
Drug resistant tuberculosis.Indian J Pediatr. 2000 Feb;67(2 Suppl):S41-6. Indian J Pediatr. 2000. PMID: 11129907 Review.
-
Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?Bull World Health Organ. 2000;78(2):238-51. Bull World Health Organ. 2000. PMID: 10743297 Free PMC article.
-
Status of drug resistance in tuberculosis after the introduction of rifampicin in India.J Indian Med Assoc. 2003 Mar;101(3):154-6. J Indian Med Assoc. 2003. PMID: 14603961
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
[Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].Rev Invest Clin. 2001 Jul-Aug;53(4):315-23. Rev Invest Clin. 2001. PMID: 11599478 Spanish.